nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of missed ocular torticollis
|
Toopchizadeh, Vahideh |
|
2016 |
|
2 |
p. 49-50 |
artikel |
2 |
Advancing our understanding of osteocyte cell biology
|
Dayong Guo, |
|
2009 |
|
2 |
p. 87-96 |
artikel |
3 |
Aging and bone loss: new insights for the clinician
|
Demontiero, Oddom |
|
2012 |
|
2 |
p. 61-76 |
artikel |
4 |
Apremilast in the treatment of psoriatic arthritis: a perspective review
|
Reed, Michael |
|
2017 |
|
2 |
p. 45-53 |
artikel |
5 |
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
|
Kuriya, Bindee |
|
2017 |
|
2 |
p. 37-44 |
artikel |
6 |
Botulinum toxin therapy for osteoarticular pain: an evidence-based review
|
Singh, Jasvinder A. |
|
2010 |
|
2 |
p. 105-118 |
artikel |
7 |
Can hip fracture prediction in women be estimated beyond bone mineral density measurement alone?
|
Geusens, Piet |
|
2010 |
|
2 |
p. 63-77 |
artikel |
8 |
Diagnosis and therapeutic options for peripheral vasculitic neuropathy
|
Blaes, Franz |
|
2015 |
|
2 |
p. 45-55 |
artikel |
9 |
Diagnosis and treatment of inflammatory myopathy: issues and management
|
Castro, Christine |
|
2012 |
|
2 |
p. 111-120 |
artikel |
10 |
Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis
|
Syngle, Ashit |
|
2016 |
|
2 |
p. 42-48 |
artikel |
11 |
Distal biceps reconstruction 13 years post-injury
|
Burrus, M. Tyrrell |
|
2015 |
|
2 |
p. 56-59 |
artikel |
12 |
Dual-energy X-ray absorptiometry versus quantitative ultrasonography in diagnosing osteoporosis in patients with refractory epilepsy and chronic antiepileptic drug use
|
Beerhorst, Kim |
|
2013 |
|
2 |
p. 59-66 |
artikel |
13 |
Effects of diacerein at the molecular level in the osteoarthritis disease process
|
Martel-Pelletier, Johanne |
|
2010 |
|
2 |
p. 95-104 |
artikel |
14 |
Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis
|
Clain, Jeremy M. |
|
2014 |
|
2 |
p. 58-74 |
artikel |
15 |
Febuxostat treatment for gout: what the clinician needs to know
|
Chen, Lan X. |
|
2009 |
|
2 |
p. 67-69 |
artikel |
16 |
Glucocorticoid-induced osteoporosis: treatment update and review
|
Fraser, Lisa-Ann |
|
2009 |
|
2 |
p. 71-85 |
artikel |
17 |
Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study
|
Bottegoni, Carlo |
|
2016 |
|
2 |
p. 35-41 |
artikel |
18 |
Intra-articular hyaluronan injections for the treatment of osteoarthritis: perspective for the mechanism of action
|
Piuzzi, Nicolas S. |
|
2018 |
|
2 |
p. 55-57 |
artikel |
19 |
Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab
|
Cook, Andrew D. |
|
2018 |
|
2 |
p. 29-38 |
artikel |
20 |
Is there a future for selective estrogen-receptor modulators in osteoporosis?
|
Güerri-Fernández, Roberto C. |
|
2012 |
|
2 |
p. 55-59 |
artikel |
21 |
Juvenile idiopathic arthritis: management and therapeutic options
|
Ruth, Natasha M. |
|
2012 |
|
2 |
p. 99-110 |
artikel |
22 |
Management of primary Sjögren’s syndrome: recent developments and new classification criteria
|
Del Papa, Nicoletta |
|
2018 |
|
2 |
p. 39-54 |
artikel |
23 |
NICE: its influence in treating osteoporosis in the UK and beyond
|
Compston, Juliet |
|
2009 |
|
2 |
p. 63-66 |
artikel |
24 |
Paget’s disease of bone: a review of epidemiology, pathophysiology and management
|
Shaker, Joseph L. |
|
2009 |
|
2 |
p. 107-125 |
artikel |
25 |
Personalized medicine for osteoarthritis: where are we now?
|
Sawitzke, Allen Dale |
|
2013 |
|
2 |
p. 67-75 |
artikel |
26 |
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations
|
Sokolove, Jeremy |
|
2013 |
|
2 |
p. 77-94 |
artikel |
27 |
Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases
|
Lewiecki, E. Michael |
|
2014 |
|
2 |
p. 48-57 |
artikel |
28 |
Role of ultrasound in the understanding and management of vasculitis
|
Schmidt, Wolfgang A. |
|
2014 |
|
2 |
p. 39-47 |
artikel |
29 |
The efficacy and safety of abatacept in rheumatoid arthritis
|
Westhovens, Rene |
|
2010 |
|
2 |
p. 89-94 |
artikel |
30 |
Therapeutic effects of prolotherapy with intra-articular dextrose injection in patients with moderate knee osteoarthritis: a single-arm study with 6 months follow up
|
Eslamian, Fariba |
|
2015 |
|
2 |
p. 35-44 |
artikel |
31 |
Treatment and management of pseudogout: insights for the clinician
|
MacMullan, Paul |
|
2012 |
|
2 |
p. 121-131 |
artikel |
32 |
Trigger finger: ultrasound-guided injection with an in-plane approach under the A1 pulley
|
Yildizgören, Mustafa T. |
|
2016 |
|
2 |
p. 51-52 |
artikel |
33 |
Understanding personalized medicine in rheumatoid arthritis: a clinician’s guide to the future
|
Burgos, Paula I. |
|
2009 |
|
2 |
p. 97-105 |
artikel |
34 |
Use magnetic resonance imaging to assess articular cartilage
|
Wang, Yuanyuan |
|
2012 |
|
2 |
p. 77-97 |
artikel |
35 |
Use of febuxostat in the management of gout in the United Kingdom
|
Waller, Arabella |
|
2017 |
|
2 |
p. 55-64 |
artikel |
36 |
Using hand bone mass measurements to assess progression of rheumatoid arthritis
|
Hoff, Mari |
|
2010 |
|
2 |
p. 79-87 |
artikel |